370 related articles for article (PubMed ID: 32661928)
1. Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic.
Haslak F; Yildiz M; Adrovic A; Sahin S; Koker O; Aliyeva A; Barut K; Kasapcopur O
Rheumatol Int; 2020 Sep; 40(9):1423-1431. PubMed ID: 32661928
[TBL] [Abstract][Full Text] [Related]
2. [Hereditary periodical fever syndromes].
Herlin T; Sørensen N; Veirum J
Ugeskr Laeger; 2011 Mar; 173(13):968-73. PubMed ID: 21453638
[TBL] [Abstract][Full Text] [Related]
3. Autoinflammatory syndromes.
Hashkes PJ; Toker O
Pediatr Clin North Am; 2012 Apr; 59(2):447-70. PubMed ID: 22560579
[TBL] [Abstract][Full Text] [Related]
4. Does immunosuppressive treatment entail an additional risk for children with rheumatic diseases? A survey-based study in the era of COVID-19.
Koker O; Demirkan FG; Kayaalp G; Cakmak F; Tanatar A; Karadag SG; Sonmez HE; Omeroglu R; Aktay Ayaz N
Rheumatol Int; 2020 Oct; 40(10):1613-1623. PubMed ID: 32743705
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hereditary autoinflammatory diseases.
Ter Haar NM; Frenkel J
Curr Opin Rheumatol; 2014 May; 26(3):252-8. PubMed ID: 24667287
[TBL] [Abstract][Full Text] [Related]
6. Colchicine may not be effective in COVID-19 infection; it may even be harmful?
Cumhur Cure M; Kucuk A; Cure E
Clin Rheumatol; 2020 Jul; 39(7):2101-2102. PubMed ID: 32394215
[No Abstract] [Full Text] [Related]
7. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
Eroglu FK; Beşbaş N; Topaloglu R; Ozen S
Rheumatol Int; 2015 Oct; 35(10):1733-7. PubMed ID: 26001859
[TBL] [Abstract][Full Text] [Related]
8. Monogenic Periodic Fever Syndromes: Treatment Options for the Pediatric Patient.
Ozen S; Demir S
Paediatr Drugs; 2017 Aug; 19(4):303-311. PubMed ID: 28497352
[TBL] [Abstract][Full Text] [Related]
9. The systemic autoinflammatory disorders for dermatologists. Part 2: disease examples.
Oldham J; Lachmann HJ
Clin Exp Dermatol; 2020 Dec; 45(8):967-973. PubMed ID: 32882069
[TBL] [Abstract][Full Text] [Related]
10. The challenge of autoinflammatory syndromes: with an emphasis on hyper-IgD syndrome.
van der Meer JW; Simon A
Rheumatology (Oxford); 2016 Dec; 55(suppl 2):ii23-ii29. PubMed ID: 27856657
[TBL] [Abstract][Full Text] [Related]
11. Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases.
Bettiol A; Lopalco G; Emmi G; Cantarini L; Urban ML; Vitale A; Denora N; Lopalco A; Cutrignelli A; Lopedota A; Venerito V; Fornaro M; Vannacci A; Rigante D; Cimaz R; Iannone F
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30999610
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies.
Sanchez-Piedra C; Diaz-Torne C; Manero J; Pego-Reigosa JM; Rúa-Figueroa Í; Gonzalez-Gay MA; Gomez-Reino J; Alvaro-Gracia JM;
Ann Rheum Dis; 2020 Jul; 79(7):988-990. PubMed ID: 32503857
[No Abstract] [Full Text] [Related]
13. Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States.
Hur P; Lomax KG; Ionescu-Ittu R; Manceur AM; Xie J; Cammarota J; Gautam R; Sanghera N; Kim N; Grom AA
Pediatr Rheumatol Online J; 2021 Sep; 19(1):143. PubMed ID: 34521444
[TBL] [Abstract][Full Text] [Related]
14. Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial.
Deftereos SG; Giannopoulos G; Vrachatis DA; Siasos GD; Giotaki SG; Gargalianos P; Metallidis S; Sianos G; Baltagiannis S; Panagopoulos P; Dolianitis K; Randou E; Syrigos K; Kotanidou A; Koulouris NG; Milionis H; Sipsas N; Gogos C; Tsoukalas G; Olympios CD; Tsagalou E; Migdalis I; Gerakari S; Angelidis C; Alexopoulos D; Davlouros P; Hahalis G; Kanonidis I; Katritsis D; Kolettis T; Manolis AS; Michalis L; Naka KK; Pyrgakis VN; Toutouzas KP; Triposkiadis F; Tsioufis K; Vavouranakis E; Martinèz-Dolz L; Reimers B; Stefanini GG; Cleman M; Goudevenos J; Tsiodras S; Tousoulis D; Iliodromitis E; Mehran R; Dangas G; Stefanadis C;
JAMA Netw Open; 2020 Jun; 3(6):e2013136. PubMed ID: 32579195
[TBL] [Abstract][Full Text] [Related]
15. Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs.
Michelena X; Borrell H; López-Corbeto M; López-Lasanta M; Moreno E; Pascual-Pastor M; Erra A; Serrat M; Espartal E; Antón S; Añez GA; Caparrós-Ruiz R; Pluma A; Trallero-Araguás E; Barceló-Bru M; Almirall M; De Agustín JJ; Lladós J; Julià A; Marsal S
Semin Arthritis Rheum; 2020 Aug; 50(4):564-570. PubMed ID: 32425260
[TBL] [Abstract][Full Text] [Related]
16. International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome.
Ozen S; Kuemmerle-Deschner JB; Cimaz R; Livneh A; Quartier P; Kone-Paut I; Zeft A; Spalding S; Gul A; Hentgen V; Savic S; Foeldvari I; Frenkel J; Cantarini L; Patel D; Weiss J; Marinsek N; Degun R; Lomax KG; Lachmann HJ
Arthritis Care Res (Hoboken); 2017 Apr; 69(4):578-586. PubMed ID: 27723279
[TBL] [Abstract][Full Text] [Related]
17. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study.
Qiu H; Wu J; Hong L; Luo Y; Song Q; Chen D
Lancet Infect Dis; 2020 Jun; 20(6):689-696. PubMed ID: 32220650
[TBL] [Abstract][Full Text] [Related]
18. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.
Hasseli R; Mueller-Ladner U; Schmeiser T; Hoyer BF; Krause A; Lorenz HM; Regierer AC; Richter JG; Strangfeld A; Voll RE; Pfeil A; Schulze-Koops H; Specker C
RMD Open; 2020 Sep; 6(2):. PubMed ID: 32878994
[TBL] [Abstract][Full Text] [Related]
19. Lessons from characterization and treatment of the autoinflammatory syndromes.
Aksentijevich I; McDermott MF
Curr Opin Rheumatol; 2017 Mar; 29(2):187-194. PubMed ID: 27906774
[TBL] [Abstract][Full Text] [Related]
20. Should patients stop their biologic treatment during the COVID-19 pandemic.
Bashyam AM; Feldman SR
J Dermatolog Treat; 2020 Jun; 31(4):317-318. PubMed ID: 32191143
[No Abstract] [Full Text] [Related]
[Next] [New Search]
